Skip to main content
. Author manuscript; available in PMC: 2014 Nov 15.
Published in final edited form as: Cancer. 2013 Aug 26;119(22):3976–3983. doi: 10.1002/cncr.28326

Table 5.

Lung Cancer Deaths by Gender, Histology and Arm

Men Women
LDCT CXR Mortality RR
(95% CI)
LDCT CXR Mortality RR
(95% CI)
Histologic Type N(%)
BAC 10 (3) 6 (2) 1.7 (0.6–4.4) 3 4 0.75 (0.2–3.0)
Adenocarcinoma 85 (27) 111 (33) 0.77 (0.6–1.02) 51 70 0.73 (0.51–1.05)
Large Cell 11 (3) 18 (5) 0.61 (0.3–1.3) 6 6 1.0 (0.3–3.0)
NSCLC-other 1 15 (5) 21 (6) 0.71 (0.4–1.4) 10 13 0.77 (0.4–1.7)
NSCLC-NOS 26 (8) 42 (12) 0.62 (0.4–1.01) 19 34 0.56 (0.3–0.98)
  All NSCLC minus squamous (excl BAC) 137 (44) 192 (57) 0.71 (0.6–0.9) 86 123 0.70 (0.5–0.9)
Squamous Cell 77 (25) 59 (18) 1.31 (0.9–1.8) 25 (16) 24 (11) 1.04 (0.6–1.8)
Small Cell 68 (22) 62 (18) 1.10 (0.8–1.6) 34 51 (24) 0.67 (0.4–1.03)
Carcinoid 1 (0.3) 0 0 0
Unknown 13 (4) 7 (2) 1.9 (0.8–4.5) 14 10 1.4 (0.6–3.1)
  All except small cell and squamous cell 166 (53) 216 (64) 0.77 (0.6–0.9) 99 140 0.71 (0.5–0.9)
  All except small cell 243 (78) 275 (82) 0.88 (0.7–1.05) 124 164 0.76 (0.6–0.96)
All 311 337 0.92 (0.8–1.08) 158 215 0.73 (0.6–0.9)
1

. Excludes Adenocarinoma, Large Cell, Squamous Cell, BAC and NSCLC-NOS.